Basis of Presentation and Summary of Significant Accounting Policies, Net Loss Per Share (Details) - shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Net Loss Per Share [Abstract]
Potential common stock equivalents (in shares)	5,126,344	4,402,779
Restricted Stock Units [Member]
Antidilutive Securities Excluded from Computation of Net Loss Per Share [Abstract]
Potential common stock equivalents (in shares)	278,004	90,540
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Net Loss Per Share [Abstract]
Potential common stock equivalents (in shares)	4,474,714	3,938,613
Common Stock Warrants [Member]
Antidilutive Securities Excluded from Computation of Net Loss Per Share [Abstract]
Potential common stock equivalents (in shares)	373,626	373,626